Mainbanner 1

Healthcare Professionals

Lanluma is now available in UK and EU territories. Watch our launch event in English with Spanish, French and German translations available below.

Model is not an actual patient.

Sinclair Pharma has been committed to skin expertise since 1971, and more recently to the development of a safe, minimally invasive and effective portfolio of aesthetic treatments including Lanluma.

A top quality product. My patients are loving the results – long lasting and so many smiles and thank yous! My team are loving the different size options, and the quick prep time. The quality and care really makes Lanluma stand out.
HCP Packshot2

Contact us and get started with Lanluma

INDICATION

Lanluma is a poly-L-lactic acid implant suitable for increasing the volume of depressed areas, particularly to correct skin depressions

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them.

INDICATION

Lanluma is a poly-L-lactic acid implant suitable for increasing the volume of depressed areas, particularly to correct skin depressions.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising. For a full list consult Instructions for Use.

The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised Lanluma distributor. Alternatively send the details to Sinclair on: [email protected]

For a full list of contraindications, warnings and precautions for this product please visit https://www.sinclairpharma.com/eifu for copy of the Product Instructions for Use.